From The Motley Fool · Seena Hassouna · · 1m 40s
Astera Labs vs Arm: 2027 Tech Stock Pick
Astera Labs' AI connectivity growth beats Arm's steady licensing for 2027 investors.
In brief
Astera Labs' AI connectivity growth beats Arm's steady licensing for 2027 investors. Astera Labs is the better 2027 tech stock buy due to faster AI infrastructure growth and lower valuation risks than Arm. Originally reported by The Motley Fool.
Astera Labs' AI Connectivity Focus
Astera Labs delivers triple-digit revenue growth by providing essential connectivity solutions for artificial intelligence infrastructure.
“Astera Labs provides the essential connectivity hardware that links ai chips together”
Arm's Licensing Dominance
Arm maintains a dominant position in the global semiconductor ecosystem through its high-margin architecture licensing and royalty model.
“Arm operates a unique and highly profitable business model by licensing its compute architecture to the world's leading chipmakers”
Astera Labs Revenue Growth
In the 12 months ended sept 30 2026 revenue reached nearly $1.6 billion representing growth of approximately 115.2% compared to the prior twelve-month period.
“In its latest annual report astera labs noted that one end customer accounted for over 70% of revenue”
Arm Revenue Growth
In the 12 months ended sept 30 2026 revenue reached nearly $5.5 billion marking an increase of roughly 23.8% over the previous year.
“Arm earns its reputation as the steadier toll collector across phones pcs cars and data centers”
Astera Labs Financial Health
Astera labs has a current ratio of nearly 10.2x and debt-to-equity ratio of approximately 0.0x with free cash flow of nearly $281.8 million.
“The company has no debt relative to its shareholders equity”
Arm Financial Health
Arm has a current ratio of nearly 6.0x and debt-to-equity ratio of approximately 0.1x with free cash flow of nearly $979.0 million.
“The company has a conservative financial structure with plenty of liquidity to fund future research and development”
Risk Comparison
Astera faces revenue concentration with top three customers accounting for 86% of revenue and competition from broadcom marvell and credo technology group.
“The company must navigate an intensely competitive market against established giants like broadcom and marvell technology”
Valuation Metrics
Astera labs has a lower forward p/e of 53.1x and p/s ratio of 25.6x compared to arm's 89.2x and 38.9x.
“Astera looks more attractive on a relative basis with lower forward p/e and p/s ratio while delivering faster revenue growth”
2027 Stock Recommendation
Astera labs is the better 2027 tech stock buy due to early ai infrastructure growth and lower valuation risks than arm.
“Astera labs is the one i'd own for 2027 and beyond because it looks like a company early in a very long runway”
The essence
Astera Labs is the better 2027 tech stock buy due to faster AI infrastructure growth and lower valuation risks than Arm.
